Colorectal cancer screening: A guide to the guidelines

Canadian Journal of Gastroenterology

Volumn 13, Issue 5, 1999, Pages 397-402

  Rex, Douglas K ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Colorectal cancer; Endoscopy; Fecal occult blood testing; Sigmoidoscopy

Indexed keywords

ADENOMATOUS POLYP; BARIUM ENEMA; CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; CONFERENCE PAPER; DECISION MAKING; DOUBLE CONTRAST RADIOGRAPHY; GASTROINTESTINAL ENDOSCOPY; GENETIC SCREENING; HEALTH CARE POLICY; HUMAN; META ANALYSIS; MORTALITY; NON PROFIT ORGANIZATION; OCCULT BLOOD; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SIGMOIDOSCOPY;

EID: 0032981303     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/264717     Document Type: Conference Paper

References (61)

1. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
2. Byers T, Levin B, Rothenberger D. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin 1997;47:154-60.
3. Report of the US Preventive Services Task Force. Guide to Clinical to Preventive Services. Baltimore: Williams and Wilkins, 1989.
4. US Preventive Services Task Force: Guide to Clinical Preventive Services: Report of the US Preventive Services Task Force, 2nd edn. Washington: Government Printing Office, 1996.
5. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
6. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomized study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
7. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomized control trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
8. Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Pract 1997;45:211-8.
9. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. Effective fecal occult blood testing and mortality from colorectal cancer. A case-control study. Ann Intern Med 1993;118:1-6.
10. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
11. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
12. Rex DK. Screening for colorectal cancer and polyps in average-risk persons. In: Schapiro M, Lehman GA, eds. Flexible Sigmoidoscopy Techniques and Utilization. Baltimore: Williams & Wilkins, 1990:185-96.
13. Rex DK, Lehman GA, Ulbright TM, et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 1993;88:825-31.
14. Johnson DA, Gurney MS, Volpe RJ, et al. A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk. Am J Gastroenterol 1990;85:969-74.
15. Foutch PG, Mai H, Pardy K, DiSario JA, Manne RK, Kerr D. Flexible sigmoidoscopy may be ineffective for secondary prevention of colorectal cancer in asymptomatic, average-risk men. Dig Dis Sci 1991;36:924-8.
16. Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991;86:946-51.
17. Rogge JD, Elmore MF, Mahoney SJ, et al. Low cost, office-based, screening colonoscopy. Am J Gastroenterol 1994;89:1775-80.
18. Baker JW, Gathright JB Jr, Timmcke AE, Hicks TC, Ferrari BT, Ray JE. Colonoscopic screening of asymptomatic patients with a family history of colon cancer. Dis Colon Rectum 1990;33:926-30.
19. Grossman S, Milos ML. Colonoscopic screening of person with suspected risk factors for colon cancer. Gastroenterology 1988;94:395-400.
20. Gryska PV, Cohen AM. Screening asymptomatic patients with high risk for colon cancer with full colonoscopy. Dis Colon Rectum 1992;35:523-9.
21. Guillem JO, Forde KA, Treat MR, Neugut AI, O'Toole KM, Diamond BE. Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. A controlled, prospective study. Dis Colon Rectum 1992;35:523-9.
22. Luchtefeld MA, Syverson D, Solfelt M, et al. Is colonoscopic screening appropriate in asymptomatic patients with family history of colon cancer? Dis Colon Rectum 1991;34:763-8.
23. McConnell JC, Nizin JS, Slade MS. Colonoscopy in patients with a primary family history of colon cancer. Dis Colon Rectum 1990;33:105-7.
24. Meagher AP, Stuart M. Colonoscopy in patients with a family history of colorectal cancer. Dis Colon Rectum 1992;35:315-21.
25. Orrom WJ, Brzezinski WS, Wiens EW. Heredity and colorectal cancer: A prospective, community-based, endoscopic study. Dis Colon Rectum 1990;33:490-3.
26. Rozen P, Roin E. A cost analysis of screening methodology for family members of colorectal cancer patients. Am J Castroenterol 1989;84:1548-51.
27. Gaglia P, Atkins WS, Whitelaw S, et al. Variables associated with the risk of colorectal adenomas in asymptomatic patients with a family history of colorectal cancer. Gut 1995;36:385-90.
28. Bazzoli F, Fossi S, Sottili S, et al. The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer. Gastroenterology 1995;109:783-8.
29. Lanspa SJ, Lynch HT, Smyrk TC, et al. Colorectal adenomas in the Lynch syndromes. Results of a Colonoscopy screening program. Gastroenterology 1990;98:1117-22.
30. Love RR, Morrissey JF. Colonoscopy in asymptomatic individuals with a family history of colorectal cancer. Arch Intern Med 1984;144:2209-11.
31. Vansen HFA, Jafer FCA, Memko FH. Screening for hereditary non-polyposis colorectal cancer: A study of 22 kindreds in the Netherlands. Am J Med 1989;86:278-81.
32. Lanspa SJ, Jenkins JX, Cavalieri J, et al. Surveillance in Lynch syndrome: How aggressive? Am J Gastroenterol 1994;89:1978-80.
33. Järvinén HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405-11.
34. Johnson CD, Ilstrup DM, Fish NM, et al. Barium enema: detection of colonic lesions in a community population. AJR Am J Roentgenol 1996;167:39-43.
35. Rex DK, Lehman GA, Ulbright TM, Smith JJ, Hawes RH. The yield of a second screening flexible sigmoidoscopy in average-risk persons after one negative examination. Gastroenterology 1994;106:593-5.
36. Rex DK, Cummings OW, Helper DJ, et al. 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons. Gastroenterology 1996;111:1178-81.
37. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995;109:1781-90.
38. Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood tests: a background paper. Ann Intern Med 1997;126:811-22.
39. Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997;112:17-23.
40. Lemmel GT, Haseman JH, Rex DK, Rahmani E. Neoplasia distal to the splenic flexure in persons with proximal colon cancer. Gastrointest Endosc 1996;44:109-11.
41. Office of Technology Assessment. Cost-effectiveness of Colorectal Cancer Screening in Average-Risk Adults. Washington: United States Congress, 1995.
42. Zauber A. Presentation at Digestive Disease Week, New Orleans, May 1994.
43. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-81.
44. Jørgensen OD, Kronborg O, Fenger C. The Funen adenoma follow-up study: Incidence and death from colorectal carcinoma in an adenoma surveillance program. Scand J Gastroenterol 1993;28:869-74.
45. Rex DK. Colonoscopy: A review of its yield for cancer and adenomas by indication. Am J Gastroenterol 1995;3:353-65.
46. Herman FN. Avoidance of sedation during total colonoscopy. Dis Colon Rectum 1990;33:70-2.
47. Seow-Choen F, Leong AFPK, Tsang CH. Selective sedation for colonoscopy. Gastrointest Endosc 1994;40:661-4.
48. Ristikankare MKO, Julkenen RJK. Pre-medication for gastrointestinal endoscopy as a rare practice in Finland: a nation wide survey. Gastrointest Endosc 1998;47:204-7.
49. Waye JD, Lewis BS, Yessayan S. Colonoscopy: a prospective report of complications. J Clin Gastroenterol 1992;15:347-51.
50. Basson MD, Etter L, Panzini LA. Rates of colonoscopic perforation in current practice. Gastroenterology 1998;114:1115.
51. St John DJ, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993;118:785-90.
52. Lovett E. Family studies in cancer of the colon and rectum. Br J Surg 1976;63:13-8.
53. Macklin MT. Inheritance of cancer of the stomach and large intestine in man. J Natl Cancer Inst 1960;224:551-71.
54. Woolf CM. A genetic study of carcinoma of the large intestine. Am J Hum Genet 1958;10:42-7.
55. Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps: National Polyp Study Workgroup. N Engl J Med 1996;334:82-7.
56. Rex DK. Barium enema 1995: Where are we now? Endoscopy 1995;27:200-2.
57. Kewenter J, Breging H, Engarås B, et al. Value of flexible sigmoidoscopy and double-contrast barium enema in the diagnosis of neoplasms in the rectum and colon in subjects with a positive hemoccult: results of 1831 rectosigmoidoscopies and double-contrast barium enemas. Endoscopy 1995;27:501-3.
58. Vellacott KD, Amar SS, Hardcastle JD. Comparison of rigid and flexible sigmoidoscopy with double contrast barium enemas. Br J Surg 1982;69:399-400.
59. Williams CB, Macrae FA, Bartram CI. A prospective study of diagnostic methods in adenoma follow-up. Endoscopy 1982;14:74-5.
60. Luce MC, Marr AG, Chauhan DP, et al. In vitro transcription/ translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology 1995;109:1368-74.
61. Powell SM, Petersen GM, Krush AJ, et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993;329:1982-7.